Robert Mayer
Overview
Explore the profile of Robert Mayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1288
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abou-Alfa G, Mayer R, Venook A, ONeill A, Beg M, LaQuaglia M, et al.
Oncologist
. 2020 Mar;
25(12):e1837-e1845.
PMID: 32154962
Lessons Learned: The fibrolamellar carcinoma-associated DNAJB1-PRKACA gene fusion transcript RNA codes for the catalytic domain of protein kinase A and, thus, overexpression of Aurora kinase A. ENMD-2076 showed a favorable...
2.
Muere A, Tripp D, Nickel J, Kelly K, Mayer R, Pontari M, et al.
Pain Manag Nurs
. 2018 Mar;
19(5):497-505.
PMID: 29501360
Background: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a urologic chronic pelvic pain syndrome with suboptimal treatment outcomes. Catastrophizing is an empirically supported risk factor for greater IC/BPS pain. Aims: In...
3.
Katz L, Tripp D, Carr L, Mayer R, Moldwin R, Nickel J
BJU Int
. 2017 Apr;
120(2):286-292.
PMID: 28386966
Objectives: To examine a self-regulation and coping model for interstitial cystitis/bladder pain syndrome (IC/BPS) that may help us understand the pain experience of patients with chronic IC/BPS. Patients And Methods:...
4.
Tripp D, Nickel J, Krsmanovic A, Pontari M, Moldwin R, Mayer R, et al.
Can Urol Assoc J
. 2017 Jan;
10(11-12):383-388.
PMID: 28096911
Introduction: We sought to evaluate psychosocial factors as predictors of suicidal ideation (SI) in a tertiary care outpatient sample of women suffering from interstitial cystitis/bladder pain syndrome (IC/BPS). Methods: The...
5.
Hofmann H, Kronthaler U, Fritsch C, Grau R, Muller S, Mayer R, et al.
Expert Opin Biol Ther
. 2016 Jul;
16(10):1185-95.
PMID: 27463856
Background And Objective: Biosimilars are approved biologics that are comparable to an originator product with respect to quality, safety and efficacy. Herein, the authors describe the functional and non-clinical studies...
6.
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies
Sloane D, Govindarajulu U, Harrow-Mortelliti J, Barry W, Hsu F, Hong D, et al.
J Allergy Clin Immunol Pract
. 2016 Feb;
4(3):497-504.
PMID: 26895621
Background: Rapid drug desensitization (RDD) is used to address hypersensitivity reactions to chemotherapeutics and monoclonal antibodies, allowing patients to be treated with optimal pharmacological agents. RDD protocols are tailored to...
7.
Wu P, Noland C, Ultsch M, Edwards B, Harris D, Mayer R, et al.
J Lab Autom
. 2015 Aug;
21(1):97-106.
PMID: 26275619
Acoustic droplet ejection (ADE) enables crystallization experiments at the low-nanoliter scale, resulting in rapid vapor diffusion equilibration dynamics and efficient reagent usage in the empirical discovery of structure-enabling protein crystallization...
8.
9.
Tripp D, Nickel J, Wong J, Pontari M, Moldwin R, Mayer R, et al.
Eur Urol
. 2012 May;
62(6):1188-94.
PMID: 22633363
Background: Many bladder pain syndrome/interstitial cystitis (BPS/IC) patients report multiple pain locations outside the pelvis. No research has examined pain using a whole-body diagram, pain-associated adjustment factors, or the impact...
10.
Katz L, Tripp D, Nickel J, Mayer R, Reimann M, van Ophoven A
BJU Int
. 2012 May;
111(1):114-21.
PMID: 22578191
Objectives: To examine a biopsychosocial framework of patient disability in patients suffering from interstitial cystitis/bladder pain syndrome (IC/BPS). To evaluate the impact of psychosocial factors on the relationship between pain...